Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma

Inflamm Res. 2007 Oct;56(10):402-8. doi: 10.1007/s00011-007-7005-6.

Abstract

Objective: Eosinophils and cytokines are implicated in the pathogenesis of allergic diseases. In the present study, we investigate the anti-inflammatory effect of quercetin and isoquercitrin in a murine model of asthma.

Methods: BALB/c mice were immunized (ovalbumin/aluminum hydroxide, s. c.), followed by two intranasal ovalbumin challenges. From day 18 to day 22 after the first immunization, the mice received daily gavages of isoquercitrin (15 mg/kg) or quercetin (10 mg/kg). Dexamethasone (1 mg/kg, s. c.) was administered as a positive control. Leucocytes were analyzed in bronchoalveolar lavage fluid (BALF), blood and pulmonary parenchyma at 24 h after the last ovalbumin challenge. Interleukin-5 (IL-5) was analyzed in BALF and lung homogenates.

Results: In animals receiving isoquercitrin or quercetin, eosinophil counts were lower in the BALF, blood and lung parenchyma. Neutrophil counts in blood and IL-5 levels in lung homogenate were lower only in isoquercitrin-treated mice. No alterations in mononuclear cell numbers were observed.

Conclusion: Quercetin and isoquercitrin are effective eosinophilic inflammation suppressors, suggesting a potential for treating allergies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / immunology
  • Bronchoalveolar Lavage Fluid / immunology
  • Cell Count
  • Female
  • Interferon-gamma / analysis
  • Interleukin-5 / analysis
  • Lung / immunology
  • Mice
  • Mice, Inbred BALB C
  • Quercetin / analogs & derivatives*
  • Quercetin / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Interleukin-5
  • isoquercitrin
  • Interferon-gamma
  • Quercetin